PHARMACOTHERAPY OF PARKINSONS-DISEASE

被引：7

作者：

COHEN, MM

SCHEIFE, RT

机构：

[1] NEW ENGLAND MED CTR HOSP, DEPT NEUROL, BOSTON, MA 02111 USA

[2] NEW ENGLAND MED CTR HOSP, DEPT PHARM, BOSTON, MA 02111 USA

[3] NORTHEASTERN UNIV, SCH PHARM & ALLIED HLTH PROFESS, BOSTON, MA 02115 USA

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1977年 / 34卷 / 05期

关键词：

D O I：

10.1093/ajhp/34.5.531

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：531 / 538

页数：8

共 54 条

[21]

KLAWANS HL, 1973, PHARMACOLOGY EXTRAPY, P98

[22]

Koella W P, 1967, Int Rev Neurobiol, V10, P31, DOI 10.1016/S0074-7742(08)60150-6

[23]

KOFMAN O, 1971, CAN MED ASSOC J, V104, P483

[24]

Krnjevic K, 1974, Adv Neurol, V5, P145

[25] STUDIES ON ANTIPARKINSONIAN EFFICACY OF LERGOTRILE [J].

LIEBERMAN, A ;

MIYAMOTO, T ;

BATTISTA, AF ;

GOLDSTEIN, M .

NEUROLOGY, 1975, 25 (05) :459-462

[26] ANTIPARKINSONIAN EFFICACY OF BROMOCRIPTINE [J].

LIEBERMAN, A ;

ZOLFAGHARI, M ;

BOAL, D ;

HASSOURI, H ;

VOGEL, B ;

BATTISTA, A ;

FUXE, K ;

GOLDSTEIN, M .

NEUROLOGY, 1976, 26 (05) :405-409

[27]

LIEBERMAN A, 1976, APR AM AC NEUR TOR

[28] CARBIDOPA IN PARKINSON-DISEASE AND IN NAUSEA AND VOMITING OF LEVODOPA [J].

MARKHAM, CH ;

DIAMOND, SG ;

TRECIOKAS, LJ .

ARCHIVES OF NEUROLOGY, 1974, 31 (02) :128-133

[29] LEVODOPA, CARBIDOPA, AND PYRIDOXINE IN PARKINSON DISEASE - METABOLIC INTERACTIONS [J].

MARS, H .

ARCHIVES OF NEUROLOGY, 1974, 30 (06) :444-447

[30]

Marsden C D, 1975, Mod Trends Neurol, V6, P141

← 1 2 3 4 5 6 →